Adenomas

0
Pipeline Programs
1
Companies
1
Clinical Trials
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
0
0
Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

1 companies ranked by most advanced pipeline stage

Cosmo Pharmaceuticals
Cosmo PharmaceuticalsIreland - Dublin
1 program
Endoscopic Mucosal Resection of large colon polypsN/A1 trial
Active Trials
NCT02654418CompletedEst. Jul 2017

Trial Timeline

Clinical trial activity over time

2021
2022
2023
2024
2025
2026
Cosmo PharmaceuticalsEndoscopic Mucosal Resection of large colon polyps

Clinical Trials (1)

NCT02654418Cosmo PharmaceuticalsEndoscopic Mucosal Resection of large colon polyps

Safety Study of SIC 8000 in Subjects Undergoing Endoscopic Mucosal Resection (EMR) of Colonic Lesions Equal to or Larger Than 2 cm

Start: Feb 2016Est. completion: Jul 2017
N/ACompleted

Phase Legend

PreclinicalLab & animal studies
Phase 1Safety & dosing
Phase 2Efficacy testing
Phase 3Large-scale trials
On MarketApproved & available

Key Insights

1 companies competing in this space